Category: Specific Treatments

Specific Treatments

5-ASA

Mesalamine

Steroids

Budesonide

Infliximab

Remicade

Adalimumab

Humira

Thiopurines

Imuran, 6-MP

Vedolizumab

Entyvio

Ustekinumab

Stelara

Tofacitinib

Xeljanz

Email Newsletter

Recent News

Dual biologic therapy offers possible option for refractory IBD
April 6, 2021
7 recent reports in IBD
April 3, 2021
Gluten intake not linked with IBD risk
March 31, 2021
New understanding ofmonogenic IBD may lead to effective management
March 19, 2021
Greenspace exposure during childhood reduces risk for IBD
February 22, 2021
7 recent reports on IBD
February 20, 2021
High rate of COVID-19 vaccination intent among IBD populations
February 8, 2021
NAFLD linked with increased readmissions in IBD
January 27, 2021
Patients with IBD should receive COVID-19 vaccine, despite concerns
January 26, 2021
VIDEO: Ask patients with IBD, ‘how happy are you?’
January 26, 2021